Orlistat improves endothelial function in obese adolescents: A randomised trial

Journal of Paediatrics and Child Health

Volumn 49, Issue 11, 2013, Pages 969-975

  Yu, Clare C W ^a,b   Li, Albert M ^b   Chan, Karly O W ^a   Chook, Ping ^b   Kam, Jack T C ^a   Au, Chun T ^b   So, Raymond C H ^c   Sung, Rita Y T ^b   McManus, Alison M ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^c Hong Kong Sports Institute   (Hong Kong)

Author keywords

adolescent; endothelial function; obesity; orlistat; resistance training; weight loss

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TETRAHYDROLIPSTATIN; TRIACYLGLYCEROL;

ADOLESCENCE; ADOLESCENT; ADULT; ARTICLE; BLOOD PRESSURE; BODY FAT; BODY MASS; BODY WEIGHT; BRACHIAL ARTERY; CALORIC INTAKE; CHILD; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DIET RESTRICTION; DIET THERAPY; DRUG EFFECT; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; OBESITY; PHYSICAL ACTIVITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESISTANCE TRAINING; SCHOOL CHILD; SINGLE BLIND PROCEDURE; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE;

ADOLESCENT; ENDOTHELIAL FUNCTION; OBESITY; ORLISTAT; RESISTANCE TRAINING; WEIGHT LOSS;

ADOLESCENT; ANTHROPOMETRY; ANTI-OBESITY AGENTS; BLOOD PRESSURE DETERMINATION; CHILD; ENDOTHELIAL CELLS; ENERGY INTAKE; FASTING; FEMALE; HONG KONG; HUMANS; LACTONES; MALE; MOTOR ACTIVITY; OBESITY;

EID: 84888026034     PISSN: 10344810     EISSN: 14401754     Source Type: Journal    
DOI: 10.1111/jpc.12252     Document Type: Article

References (38)

1. Korner J, Aronne LJ,. Pharmacological approaches to weight reduction: therapeutic targets. J. Clin. Endocrinol. Metab. 2004; 89: 2616-2621.
2. Weight-control Information Network, National Institute of Diabetes and Digestive and Kidney Diseases, National Institute of Health. Prescription medications for the treatment of obesity. NIH Publication No. 07-4191. 2004 Available from: http://win.niddk.nih.gov/%20publications/pdfs/prescription- medications.pdf [accessed July 2012]. [updated December 2010].
3. Gray LJ, Cooper N, Dunkley A, et al. A systematic review and mixed treatment comparison of pharmacological interventions for the treatment of obesity. Obes. Rev. 2012; 13: 483-498.
4. Leblanc ES, O'Connor E, Whitlock EP, Patnode CD, Kapka T,. Effectiveness of primary care-relevant treatments for obesity in adults: a systematic evidence review for the U.S. Preventive Services Task Force. Ann. Intern. Med. 2011; 155: 434-447.
5. Maahs D, de Serna DG, Kolotkin RL, et al. Randomized, double-blind, placebo-controlled trial of orlistat for weight loss in adolescents. Endocr. Pract. 2006; 12: 18-28.
6. Chanoine JP, Hampl S, Jensen C, Boldrin M, Hauptman J,. Effect of orlistat on weight and body composition in obese adolescents: a randomized controlled trial. JAMA 2005; 293: 2873-2883.
7. Ozkan B, Bereket A, Turan S, Keskin S,. Addition of orlistat to conventional treatment in adolescents with severe obesity. Eur. J. Pediatr. 2004; 163: 738-741.
8. Van Houtte PM,. Obesity and Vascular dysfunction: the fat-e of rich and poor. Br. J. Pharmacol. 2012; 165: 541-543.
9. Bergholm R, Tiikkainen M, Vehkavaara S, et al. Lowering of LDL cholesterol rather than moderate weight loss improves endothelium-dependent vasodilatation in obese women with previous gestational diabetes. Diabetes Care 2003; 26: 1667-1672.
10. Sekuri C, Tavli T, Avsar A, Sozcuer H, Uyanik BS, Ari Z,. The acute effect of orlistat on endothelial function in young obese women. Int. J. Clin. Pharmacol. Res. 2003; 23: 111-117.
11. Brook RD, Bard RL, Glazewski L, et al. Effect of short-term weight loss on the metabolic syndrome and conduit vascular endothelial function in overweight adults. Am. J. Cardiol. 2004; 93: 1012-1016.
12. Singh AS, Mulder C, Twisk JW, van Mechelen W, Chinapaw MJ,. Tracking of childhood overweight into adulthood: a systematic review of the literature. Obes. Rev. 2008; 9: 474-488.
13. Lurbe E, Alvarez V, Redon J,. Obesity, body fat distribution, and ambulatory blood pressure in children and adolescents. J. Clin. Hypertens. (Greenwich) 2001; 3: 362-367.
14. Sorof JM, Lai D, Turner J, Poffenbarger T, Portman RJ,. Overweight, ethnicity, and the prevalence of hypertension in school-aged children. Pediatrics 2004; 113: 475-482.
15. Freedman DS, Mei Z, Srinivasan SR, Berenson GS, Dietz WH,. Cardiovascular risk factors and excess adiposity among overweight children and adolescents: the Bogalusa Heart Study. J. Pediatr. 2007; 150: 12-17.
16. Oude Luttikhuis H, Baur L, Jansen H, et al. Interventions for treating obesity in children. Cochrane Database Syst. Rev. 2009; (21): CD001872.
17. Tsiros MD, Sinn N, Coates AM, Howe PR, Buckley JD,. Treatment of adolescent overweight and obesity. Eur. J. Pediatr. 2008; 167: 9-16.
18. Leung SS, Cole TJ, Tse LY, Lau JT,. Body mass index reference curves for Chinese children. Ann. Hum. Biol. 1998; 25: 169-174.
19. Corretti MC, Anderson TJ, Benjamin EJ, et al. International Brachial Artery Reactivity Task Force. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. J. Am. Coll. Cardiol. 2002; 39: 257-265.
20. Celermajer DS, Sorensen KE, Gooch VM, et al. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 1992; 340: 1111-1115.
21. Institute of Medicine of the National Academies. Dietary Reference Intakes for Energy, Carbohydrates, Fiber, Fat, Fatty Acids, Cholesterol, Protein and Amino Acids. Washington D.C.: The National Academies Press, 2005; 218-219.
22. Shaw V, Lawson M,. Obesity. In:, Shaw V, Lawson M, eds. Clinical Paediatric Dietetics, 1st edn. Oxford: Blackwell Sciences, 1994; 288-289.
23. Yu CC, Sung RY, So RC, et al. Effects of strength training on body composition and bone mineral content in children who are obese. J. Strength Cond. Res. 2005; 19: 667-672.
24. So HK, Nelson EA, Li AM, et al. Secular changes in height, weight and body mass index in Hong Kong children. BMC Public Health 2008; 8: 320. doi: 10.1186/1471-2458-8-320.
25. Morris NM, Udry JR,. Validation of a self-administered instrument to assess stage of adolescent development. J. Youth Adolesc. 1980; 9: 271-280.
26. Schwartz B, Jacobs DR Jr, Moran A, Steinberger J, Hong CP, Sinaiko AR,. Measurement of insulin sensitivity in children: comparison between the euglycemic-hyperinsulinemic clamp and surrogate measures. Diabetes Care 2008; 31: 783-788.
27. Kowalski KC, Crocker PR, Faulkner RA,. Validation of the physical activity questionnaire for older children. Pediatr. Exerc. Sci. 1997; 9: 174-186.
28. Yu CC, Chan S, Cheng F, Sung RYT, Hau KT,. Are physical activity and academic performance compatible? Academic achievement, conduct, physical activity and self-esteem of Hong Kong Chinese primary school children. Educ. Stud. 2006; 32: 331-341.
29. Woo KS, Chook P, Yu CW, et al. Effects of diet and exercise on obesity-related vascular dysfunction in children. Circulation 2004; 109: 1981-1986.
30. Smith TJ, Crombie A, Sanders LF, et al. Efficacy of orlistat 60 mg on weight loss and body fat mass in US army soldiers. J. Acad. Nutr. Diet. 2012; 112: 533-540.
31. McDuffie JR, Calis KA, Uwaifo GI, et al. Efficacy of orlistat as an adjunct to behavioral treatment in overweight African American and Caucasian adolescents with obesity-related co-morbid conditions. J. Pediatr. Endocrinol. Metab. 2004; 7: 307-319.
32. Norgren S, Danielsson P, Jurold R, Lötborn M, Marcus C,. Orlistat treatment in obese prepubertal children: a pilot study. Acta Paediatr. 2003; 92: 666-670.
33. McDuffie JR, Calis KA, Uwaifo GI, et al. Three-month tolerability of orlistat in adolescents with obesity-related comorbid conditions. Obes. Res. 2002; 10: 642-650.
34. Chan KW, Leung WS, Fung YS, et al. The effects of diet and orlistat on body weight and lipid profiles in high risk Chinese patients with coronary artery disease, obesity and hypercholesterolemia. Ir. J. Med. Sci. 2009; 178: 173-178.
35. Halpern A, Mancini MC, Suplicy H, et al. Latin-American trial of orlistat for weight loss and improvement in glycaemic profile in obese diabetic patients. Diabetes Obes. Metab. 2003; 5: 180-188.
36. Krempf M, Louvet JP, Allanic H, Miloradovich T, Joubert JM, Attali JR,. Weight reduction and long-term maintenance after 18 months treatment with orlistat for obesity. Int. J. Obes. Relat. Metab. Disord. 2003; 27: 591-597.
37. Broom I, Wilding J, Stott P, Myers N, UK Multimorbidity Study Group. Randomised trial of the effect of orlistat on body weight and cardiovascular disease risk profile in obese patients: UK Multimorbidity Study. Int. J. Clin. Pract. 2002; 56: 494-499.
38. Pullin CH, Bellamy MF, Bailey D, et al. Time course of changes in endothelial function following exercise in habitually sedentary men. J. Exerc. Physiol. 2004; 7: 14-22.